UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Total30 Sphere Contact Lenses

Not Applicable

Completed

Conditions: Dry Eye
Contact Lens Complication

Interventions: Device: Total30 Sphere Contact Lenses

First Posted Date: 2022-01-10

Last Posted Date: 2022-12-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 48

Registration Number: NCT05183022

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis

Phase 4

Withdrawn

Conditions: Synkinesis
Facial Nerve Palsy

Interventions: Drug: Apraclonidine

First Posted Date: 2021-12-22

Last Posted Date: 2024-07-19

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT05167760

Impact Program for Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Behavioral: Impact of four week coaching program on dietary habits

First Posted Date: 2021-12-21

Last Posted Date: 2023-09-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 30

Registration Number: NCT05165238

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke

Not Applicable

Recruiting

Conditions: Stroke
Cognitive Dysfunction

Interventions: Behavioral: Speed of Processing Training
Behavioral: Instrumental Activities of Daily Living In-lab Training
Behavioral: Cognitive Transfer Packagke
Behavioral: Family Caregiver Coaching
Behavioral: Healthy Lifestyle In-lab Training
Behavioral: Follow-up Phone Calls
Behavioral: Healthy Lifestyle Transfer Package

First Posted Date: 2021-12-17

Last Posted Date: 2024-05-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 120

Registration Number: NCT05162781

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Mitochondrial Dysfunction Contributes to Sepsis Induced Cardiac Dysfunction

Not yet recruiting

Conditions: Sepsis

Interventions: Diagnostic Test: Suspected Sepsis Group - Diagnostic Measurements
Diagnostic Test: Control Group - Diagnostic Measurements

First Posted Date: 2021-12-08

Last Posted Date: 2025-01-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT05148117

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom

Not Applicable

Completed

Conditions: Glioblastoma

Interventions: Device: Point-of-care Portable Perfusion Phantom (P4)

First Posted Date: 2021-12-02

Last Posted Date: 2025-02-14

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT05140902

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluation of the Lakeshore Online Fitness Program

Not Applicable

Completed

Conditions: Physically Disabled

Interventions: Behavioral: Exercise

First Posted Date: 2021-12-01

Last Posted Date: 2024-05-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 33

Registration Number: NCT05138809

Locations: 🇺🇸
Lakeshore Foundation, Homewood, Alabama, United States

Black Health Identification Program (B-HIP)

Not Applicable

Completed

Conditions: Multiple Chronic Conditions
Family Members

Interventions: Behavioral: "My Health Priorities" Identification Program

First Posted Date: 2021-11-22

Last Posted Date: 2024-07-01

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 30

Registration Number: NCT05129709

Locations: 🇺🇸
The Whitaker Clinic at the University of Alabama at Birmingham, Birmingham, Alabama, United States

An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis

Early Phase 1

Active, not recruiting

Conditions: Nail Psoriasis

Interventions: Drug: Deucravacitinib

First Posted Date: 2021-11-17

Last Posted Date: 2025-03-30

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1

Registration Number: NCT05124080

Locations: 🇺🇸
University of Alabama at Birmingham - Department of Dermatology, Birmingham, Alabama, United States

Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia

Not Applicable

Recruiting

Conditions: Mental Illness
Alcohol-Related Disorders
HIV/AIDS

Interventions: Behavioral: Alcohol Brief Intervention
Behavioral: Standard of Care
Behavioral: Common Elements Treatment Approach

First Posted Date: 2021-11-16

Last Posted Date: 2023-08-14

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 680

Registration Number: NCT05121064

Locations: 🇿🇲
Kalingalinga Health Centre, Lusaka, Zambia
🇿🇲
Kamwala Health Centre, Lusaka, Zambia
🇿🇲
Chilenje Level 1 Hospital, Lusaka, Zambia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy